Fatty Acid Oxidation Defects and Insulin Sensitivity
Not Applicable
Completed
- Conditions
- Very Long-chain Acyl-CoA Dehydrogenase DeficiencyTrifunctional Protein DeficiencyLong-chain 3-hydroxyacyl-CoA Dehydrogenase DeficiencyMedium-chain Acyl-CoA Dehydrogenase DeficiencyNormal VolunteersCarnitine Palmitoyltransferase II Deficiency, Myopathic
- Interventions
- Drug: Glycerol/SalineDrug: Intralipid/HeparinDrug: Hyperinsulinemic euglycemic clamp
- First Posted Date
- 2015-08-07
- Last Posted Date
- 2024-01-30
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 41
- Registration Number
- NCT02517307
- Locations
- 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States
Screening for Sleep Disordered Breathing With Minimally Obtrusive Sensors
- Conditions
- Sleep Apnea SyndromesSnoring
- First Posted Date
- 2015-06-12
- Last Posted Date
- 2020-01-09
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 52
- Registration Number
- NCT02470182
- Locations
- 🇺🇸
Center for Spoken Language Understanding, Portland, Oregon, United States
Meditation or Health & Wellness Education Via Internet for Adults 50-80 Years Old
Not Applicable
Completed
- Conditions
- Stress, PhysiologicalStress, Psychological
- Interventions
- Behavioral: Health & Wellness EducationBehavioral: Mindfulness Meditation
- First Posted Date
- 2015-06-10
- Last Posted Date
- 2019-03-13
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 64
- Registration Number
- NCT02467660
- Locations
- 🇺🇸
Hatfield Research Center, Portland, Oregon, United States
Imaging and Omics for Cardiovascular Risk During NASA Deep Space Missions
- Conditions
- Coronary Artery Disease
- Interventions
- Procedure: Myocardial contrast echocardiography
- First Posted Date
- 2015-06-08
- Last Posted Date
- 2018-01-12
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 60
- Registration Number
- NCT02465554
- Locations
- 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States
Prospective Clinical Evaluation of the Taperguard Endotracheal Tube
Completed
- Conditions
- Postoperative Pneumonia
- First Posted Date
- 2015-05-21
- Last Posted Date
- 2018-08-21
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 102
- Registration Number
- NCT02450929
Preterm Infant Inhaled Albuterol Dosing
Phase 4
Completed
- Conditions
- Bronchopulmonary DysplasiaVery Low Birth Weight
- Interventions
- Drug: Varied albuterol dose response
- First Posted Date
- 2015-05-18
- Last Posted Date
- 2019-05-23
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 14
- Registration Number
- NCT02447250
- Locations
- 🇺🇸
Doernbecher Neonatal Care Center at Oregon Health & Science University, Portland, Oregon, United States
Improving Sleep Quality in People With Insomnia
Not Applicable
Completed
- Conditions
- Primary InsomniaPsychophysiological Insomnia
- Interventions
- Behavioral: Sleep hygiene programBehavioral: Sleep hypnosis
- First Posted Date
- 2015-05-14
- Last Posted Date
- 2016-12-15
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 40
- Registration Number
- NCT02443649
- Locations
- 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States
Rouxbe Pilot for MS
Not Applicable
Completed
- Conditions
- Multiple Sclerosis
- Interventions
- Behavioral: Cooking Course
- First Posted Date
- 2015-04-23
- Last Posted Date
- 2019-04-29
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 15
- Registration Number
- NCT02424825
- Locations
- 🇺🇸
Oregon Health & Science University Multiple Sclerosis Center., Portland, Oregon, United States
Emergency Contraception and Body Weight: Pilot Study
Phase 4
Completed
- Conditions
- ContraceptionBody Weight
- Interventions
- Drug: ECx1Drug: ECx2
- First Posted Date
- 2015-04-03
- Last Posted Date
- 2017-10-25
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 10
- Registration Number
- NCT02408692
- Locations
- 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States
Contrast Ultrasound Perfusion Imaging in PAD With Sonazoid
Phase 2
- Conditions
- Peripheral Artery Disease
- Interventions
- Drug: Contrast ultrasound of leg muscle with Sonazoid (Contrast ultrasound microvascular perfusion imaging)
- First Posted Date
- 2015-03-25
- Last Posted Date
- 2017-06-19
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 55
- Registration Number
- NCT02398266
- Locations
- 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States
© Copyright 2025. All Rights Reserved by MedPath